Toronto Dominion Bank’s AbbVie ABBV Stock Holding History

Toronto Dominion Bank’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-150,000	Closed	-$34.3M	–	2094
2025 Q4	$34.3M	Sell	150,000 -300,000	-67%	-$68.3M	0.05%	321
2025 Q3	$104M	Buy	+450,000	New	+$91.6M	0.16%	127
2025 Q1	–	Sell	-2,800	Closed	-$498K	–	1525
2024 Q4	$498K	Buy	+2,800	New	+$515K	﹤0.01%	1177
2019 Q1	–	Sell	-14,700	Closed	-$1.35M	–	1528
2018 Q4	$1.35M	Buy	+14,700	New	+$1.29M	﹤0.01%	844
2018 Q3	–	Sell	-48,000	Closed	-$4.45M	–	1370
2018 Q2	$4.45M	Buy	+48,000	New	+$4.69M	0.01%	703
2016 Q3	–	Sell	-45,000	Closed	-$2.79M	–	1190
2016 Q2	$2.79M	Buy	+45,000	New	+$2.74M	0.01%	189

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Toronto Dominion Bank's ABBV Position: Q1 2026 in Review

Toronto Dominion Bank reduced its AbbVie (ABBV) stake by 50% in Q1 2026, selling an estimated $120M and leaving 538,014 shares worth $117M. The position accounts for 0.17% of the portfolio, ranked #110.

Toronto Dominion Bank first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $247M in Q4 2025. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Toronto Dominion Bank held 538,014 shares of AbbVie worth $117M as of Q1 2026.
Toronto Dominion Bank sold 542,834 AbbVie shares in Q1 2026, an estimated $120M.
AbbVie made up 0.17% of Toronto Dominion Bank's portfolio in Q1 2026, its #110 holding.
Toronto Dominion Bank first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Toronto Dominion Bank's AbbVie position peaked at $247M in Q4 2025.
4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.